ICD-11 code 1F90.1 refers to intestinal parasitic infestation that is not otherwise specified. This code is used by healthcare professionals to classify cases where a patient is suffering from a parasitic infection in the intestines, but the specific type of parasite is unknown or unspecified.
Intestinal parasitic infestations can result from consuming contaminated food or water, poor hygiene practices, or exposure to infected individuals. Symptoms of intestinal parasitic infestations can include abdominal pain, diarrhea, weight loss, and fatigue.
Diagnosis of intestinal parasitic infestations typically involves laboratory testing of stool samples to identify the specific parasite causing the infection. Treatment may involve medications to kill the parasites and alleviate symptoms, as well as measures to prevent reinfection and promote good hygiene practices.
Table of Contents:
- #️⃣ Coding Considerations
- 🔎 Symptoms
- 🩺 Diagnosis
- 💊 Treatment & Recovery
- 🌎 Prevalence & Risk
- 😷 Prevention
- 🦠 Similar Diseases
#️⃣ Coding Considerations
In the realm of medical coding, the equivalent SNOMED CT code for the ICD-11 code 1F90.1 (Intestinal parasitic infestation not otherwise specified) is 235610002. This particular SNOMED CT code serves as a unique identifier for healthcare professionals worldwide to accurately document and communicate this specific condition. By utilizing international coding standards such as SNOMED CT, healthcare providers can ensure consistency and precision in recording diagnoses for patients with intestinal parasitic infestations. It is essential for healthcare professionals to be familiar with the corresponding SNOMED CT codes for various ICD-11 codes to promote interoperability and enhance the quality of healthcare delivery. This standardized approach to coding facilitates better communication, research, and decision-making in the healthcare industry.
In the United States, ICD-11 is not yet in use. The U.S. is currently using ICD-10-CM (Clinical Modification), which has been adapted from the WHO’s ICD-10 to better suit the American healthcare system’s requirements for billing and clinical purposes. The Centers for Medicare and Medicaid Services (CMS) have not yet set a specific date for the transition to ICD-11.
The situation in Europe varies by country. Some European nations are considering the adoption of ICD-11 or are in various stages of planning and pilot studies. However, as with the U.S., full implementation may take several years due to similar requirements for system updates and training.
🔎 Symptoms
Symptoms of 1F90.1, also known as intestinal parasitic infestation not otherwise specified, can vary depending on the type of parasite involved. Common symptoms may include abdominal pain, diarrhea, constipation, bloating, and fatigue. In some cases, individuals may also experience weight loss, malnutrition, and anemia as a result of the infestation.
Other symptoms of intestinal parasitic infestation may include nausea, vomiting, and fever. Some individuals may also notice visible signs of parasites in their stool, such as worms or eggs. Intestinal parasites can also cause skin irritation, itching, and rashes in some cases. Individuals may also experience joint pain, muscle aches, and general weakness as a result of the infestation.
It is important to note that symptoms of intestinal parasitic infestation can vary greatly among individuals, and some individuals may exhibit no symptoms at all. In cases where symptoms are present, they may come and go or worsen over time. It is crucial for individuals experiencing symptoms of intestinal parasitic infestation to seek medical attention for proper diagnosis and treatment.
🩺 Diagnosis
Diagnosing intestinal parasitic infestation not otherwise specified (1F90.1) typically involves a combination of patient history, physical examination, and laboratory tests. Patients may present with symptoms such as abdominal pain, diarrhea, weight loss, and fatigue, which can raise suspicion of a parasitic infection. A detailed history should include travel to endemic areas, exposure to contaminated water or food, and recent use of antibiotics or immunosuppressive medications.
During the physical examination, healthcare providers may look for signs of malnutrition, anemia, and dehydration, which can be associated with parasitic infestations. Abdominal tenderness, bloating, and palpable masses may also be present in some cases. However, it is important to note that the clinical manifestations of intestinal parasitic infections can vary widely depending on the type of parasite involved and the host’s immune response.
Laboratory tests play a key role in confirming the diagnosis of intestinal parasitic infestation. Stool examinations, including direct wet mounts, concentration techniques, and stool cultures, are commonly used to detect the presence of parasites or their eggs in the feces. In some cases, serologic tests, such as enzyme-linked immunosorbent assays (ELISAs) or polymerase chain reaction (PCR) tests, may be performed to identify specific parasitic antigens or DNA in the blood or other bodily fluids. Additionally, imaging studies such as ultrasound or computed tomography (CT) scans may be used to evaluate the extent of organ involvement or complications related to the infection.
💊 Treatment & Recovery
Treatment for Intestinal parasitic infestation not otherwise specified (1F90.1) typically involves the use of antiparasitic medications prescribed by a healthcare provider. These medications are designed to target and eliminate the specific parasite causing the infestation. In some cases, a combination of medications may be required to effectively treat the infection.
In addition to antiparasitic medications, individuals with intestinal parasitic infestation may also be prescribed supportive treatments to alleviate symptoms and aid in recovery. This may include medications to address gastrointestinal symptoms such as diarrhea, abdominal pain, and nausea. Rehydration therapy may also be recommended for individuals experiencing dehydration as a result of the infection.
Regular monitoring is essential throughout the treatment process to assess the effectiveness of medication and ensure that the infection is being adequately managed. Follow-up appointments with a healthcare provider may be necessary to monitor progress and make any necessary adjustments to the treatment plan. It is important for individuals undergoing treatment for intestinal parasitic infestation to adhere to their healthcare provider’s recommendations and complete the full course of prescribed medication to effectively eliminate the infection.
🌎 Prevalence & Risk
In the United States, the prevalence of 1F90.1 is difficult to accurately determine due to the lack of comprehensive data on intestinal parasitic infestations. However, it is known that certain populations, such as immigrants from developing countries and individuals experiencing homelessness or living in crowded and unsanitary conditions, are at higher risk for these types of infestations. Additionally, travel to regions with poor sanitation and hygiene practices can also increase the risk of contracting intestinal parasites.
In Europe, the prevalence of 1F90.1 varies between countries, with some regions experiencing higher rates of infestations than others. Factors such as immigration patterns, socioeconomic status, and access to healthcare play a role in the spread of intestinal parasites in Europe. In some cases, outbreaks of parasitic infestations have been linked to contaminated water sources or food products, highlighting the importance of proper sanitation and hygiene practices in preventing the spread of these infections.
In Asia, the prevalence of 1F90.1 is influenced by a variety of factors, including population density, socioeconomic conditions, and access to clean water and sanitation facilities. Countries with poor sanitation infrastructure and limited access to healthcare services are more likely to have higher rates of intestinal parasitic infestations. Additionally, cultural practices and dietary habits can also impact the prevalence of these infections in Asian populations.
In Africa, the prevalence of 1F90.1 is significantly higher compared to other regions, with a high burden of intestinal parasite infestations in many countries. Factors such as poor sanitation, lack of access to clean water, and limited healthcare resources contribute to the spread of these infections in African populations. Efforts to improve sanitation infrastructure, promote hygiene education, and provide access to healthcare services are crucial in reducing the prevalence of intestinal parasitic infestations in Africa.
😷 Prevention
To prevent 1F90.1 (intestinal parasitic infestation not otherwise specified), it is essential to maintain good personal hygiene practices. This includes washing hands thoroughly with soap and water before handling food, after using the bathroom, and after contact with animals. Keeping living areas clean and sanitized can also help prevent the spread of intestinal parasites.
It is important to avoid consuming contaminated food or water to prevent intestinal parasitic infestations. This can be achieved by consuming only properly cooked foods, washing fruits and vegetables thoroughly before eating them, and drinking clean, safe water. It is also crucial to avoid consuming raw or undercooked meat, seafood, or eggs, as they may contain parasites that can cause infections.
Regular deworming of pets and livestock can help prevent the transmission of intestinal parasites to humans. Keeping pets up to date on their vaccinations and following proper hygiene practices when handling pet waste can also reduce the risk of parasitic infestations. It is important to consult with a veterinarian for guidance on deworming schedules and other preventive measures for pets and livestock.
🦠 Similar Diseases
1F90.1 (Intestinal parasitic infestation not otherwise specified) refers to a condition in which an individual is infected with parasites in the intestines without a specific identification of the parasite. While this code specifically addresses intestinal parasitic infestations without further specification, there are several diseases that present with similar symptoms and may be considered in the differential diagnosis.
One such disease is giardiasis, which is caused by the parasite Giardia lamblia. Giardiasis is a common intestinal infection that can result in symptoms such as diarrhea, bloating, gas, and abdominal cramps. While giardiasis can be diagnosed through specific testing for the Giardia parasite, individuals with symptoms similar to 1F90.1 may be evaluated for this condition.
Another disease to consider is cryptosporidiosis, caused by the parasite Cryptosporidium. Cryptosporidiosis can lead to symptoms such as watery diarrhea, stomach cramps, nausea, and vomiting. Testing for Cryptosporidium may be necessary to confirm a diagnosis in individuals presenting with symptoms akin to those described in 1F90.1.
Additionally, individuals with symptoms of intestinal parasitic infestation not otherwise specified may also be evaluated for infection with Entamoeba histolytica, the parasite responsible for amoebiasis. Amoebiasis can cause symptoms such as diarrhea, abdominal pain, and bloody stools. Diagnosis of amoebiasis may involve stool sample testing for the presence of Entamoeba histolytica parasites.